Tumor purity-related genes for predicting the prognosis and drug sensitivity of DLBCL patients.

Zhenbang Ye Ning HuangYongliang FuRongle TianLi-Ming WangWenting Huang

Published in: eLife (2024)

This work is supported by the Shenzhen High-level Hospital Construction Fund and CAMS Innovation Fund for Medical Sciences (CIFMS) (2022-I2M-C&T-B-062).

Keyphrases

end stage renal disease
healthcare
health insurance
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
diffuse large b cell lymphoma
emergency department